EASL Policy Dialogues S2E5 - Rare but not forgotten – The challenges of living with PBC

EASL Policy Dialogues - Enhancing Treatment Adherence & Quality of life in Rare Liver DiseaseПодробнее

EASL Policy Dialogues S2E7 - Inequality in liver care – Identifying and addressing disparitiesПодробнее

EASL Policy Dialogue Episode 2 - World Liver Day - 19 April 2023Подробнее

EASL Studio Policy Dialogues - Episode 2 - The liver, alcohol, and politicsПодробнее

EASL Policy Dialogues S3E1 - Rarity and parity – Addressing inequities in rare liver diseaseПодробнее

EASL Policy Dialogues S2E9 - Preventing liver disease with policy measures: The Hepahealth II studyПодробнее

EASL Studio Policy Dialogues - Episode 1 - Drug use, viral hepatitis, and EuropeПодробнее

EASL Policy Dialogues S2E6 - Diagnosing Steatotic Liver Disease – Challenges and opportunitiesПодробнее

EASL Studio S5E04 Promo video - PBC: the itch we need to scratchПодробнее

EASL Grand Round Series: Primary Sclerosing CholangitisПодробнее

EASL Policy Dialogues - Inspiring Innovative Action Towards Viral Hepatitis EliminationПодробнее

Day 2 - EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary CholangitisПодробнее

Modifiers of Liver Disease Severity in Alagille SyndromeПодробнее

The Challenges of Reporting from the ProtestsПодробнее

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal (Patient Forum 2020)Подробнее

Liver Disease - Additional Questions and ConcernsПодробнее

Hepatitis C and beyond: Never a dull momentПодробнее